Skip to main content
68°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Health care industry
Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Health care industry
Healthy Returns
Health & Science
From
CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
Tags
Consumer Finance
Meta Platforms Inc
Economy
From
CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
Tags
Jobs
Bitcoin
Technology
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
US: News
Eli Lilly and Co
Business News
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Biotech and Pharmaceuticals
Apple Inc
Social issues
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Abbott Laboratories
Healthy Returns
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Tuesday
September 03, 2024
Tags
Markets
Politics
Investment strategy
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Europe News
Markets
Europe Markets
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Health care industry
Pharmaceuticals
Health & Science
From
CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
August 21, 2024
Tags
Pharmaceuticals
Costco Wholesale Corp
Health & Science
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Science
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Abbvie Inc
AstraZeneca PLC
Health & Science
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Healthy Returns
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Business News
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Zealand Pharma A/S
Augmedix Inc
Viking Therapeutics Inc
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Business
Health care industry
Companies
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Novo Nordisk A/S
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Biotech and Pharmaceuticals
Johnson & Johnson
Merck & Co Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Business
Pharmaceuticals
Zealand Pharma A/S
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Healthy Returns
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Pharmaceuticals
Health & Science
Pfizer Inc
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Investment strategy
Investment Strategy
Business
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.